Fed's Daly said she is unable to make a decision at this time and cannot give misleading forward guidance on interest rates.

Since SpaceX's record IPO last month, investors have lacked sufficient analyst financial forecasts to value the stock. That will change from next Tuesday, when the quiet period for analysts at the IPO's lead underwriters — Goldman Sachs, Morgan Stanley, BofA, Citigroup and JP Morgan, plus 18 other banks — expires. A wave of research reports, price targets and growth forecasts is expected to hit the market and should affect near‑term and multi‑year pricing. B. Riley Wealth chief market strategist Art Hogan said market discussion has focused on what the company might become by 2030 rather than its next 12 months, but investors still need to monitor the next four years.

A股创新药板块午后回暖，科伦药业、泽璟制药盘中创新高，海南海药4连板，石药景峰、联化科技涨停，热景生物涨超15%，石药创新、万邦医药、津药药业、康芝药业、双鹭药业跟涨。